United States· US:0037-0431_374f8c69-4219-47fd-aeda-8edc73da5411

Felbatol

A felbamate product containing felbamate, registered in United States by Viatris Specialty LLC. The same ATC class is registered in 9 of our 19 countries.

ATC N03AX10US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFelbatolATCN03AX10REGISTER NO.US:0037-0431_374f8c69…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Felbamate is registered in 9 of 19 countries.

Countries holding a registration under ATC N03AX10 (felbamate), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 6 of them publish a price we can compare per daily dose

Felbamate · ATC N03AX10

9 / 19 countries

  • Belgiumprice
  • Franceprice
  • Germany
  • Italyprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of felbamate costs, country by country.

Normalised to the WHO defined daily dose (2.4 g), the median price runs from $4.40 in United States to $10.58 in Switzerland — a ×2.4 gap.

  • United States: $4.40 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Felbamate · price per daily dose (2.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$10.58
  • IT Italy$9.01
  • US United States$4.40 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
FELBAMATE
Manufacturer
Viatris Specialty LLC
Country
United States (US)
ATC code
N03AX10
ATC class
Felbamate
Defined daily dose
2.4 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0037043101
    100 TABLET in 1 BOTTLE, PLASTIC (0037-0431-01)
  • ndc11
    0037-0431-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

267 interactions on record for felbamate.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Felbamate · interactions on record

267 records

  • 12 severe
  • 221 moderate
  • 7 minor

Most severe, free to view

  • Levonorgestrel and ethinylestradiolG03AA07severe
  • Desogestrel and ethinylestradiolG03AA09severe
  • Drospirenone and ethinylestradiolG03AA12severe
  • EthinylestradiolG03CA01severe

27 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Felbamate in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All felbamate products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Taloxa
  • Belgium · Taloxa-Susp, Taloxa-Tabs
  • Germany · Taloxa, Taloxa Saft
  • France · Taloxa
  • Hungary · Taloxa
  • Italy · Taloxa
  • Luxembourg · Taloxa-Susp, Taloxa-Tabs
  • Netherlands · Taloxa-Susp, Taloxa-Tabs
  • Norway · Taloxa
  • Portugal · Taloxa
  • Sweden · Taloxa

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ece294fa-ac3c-41f3-a7e8-050078f03a9c
GET /v1/drugs/ece294fa-ac3c-41f3-a7e8-050078f03a9c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "600",
  "substance": "FELBAMATE",
  "productndc": "0037-0431",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA020189",
  "marketing_category": "NDA"
}

See everything about felbamate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.